There seems to be a lot of confusion about what the recent process with the FDA was. My understanding is that the first announcement was never going to be a straight forward go-ahead. They engaged with the FDA to figure out exactly what they wanted in the phase 3 IND application. They told PAR what they want, and PAR can now go ahead and submit for formal approval.
PAR have done a bad job at communicating that, because clearly many were expecting a green light straight away, but that was never possible in the first place. My understanding could be wrong though.
IMO only.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.020(5.00%) |
Mkt cap ! $165.9M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 42.0¢ | 39.5¢ | $122.4K | 300.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 10217 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 6810 | 2 |
View Market Depth
| Last trade - 11.52am 22/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |